ReWalk Robotics Ltd. (NASDAQ:LFWD – Get Free Report) CEO Lawrence J. Jasinski sold 2,665 shares of the stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $3.84, for a total value of $10,233.60. Following the completion of the sale, the chief executive officer now directly owns 103,309 shares of the company’s stock, valued at approximately $396,706.56. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
ReWalk Robotics Stock Up 0.3 %
Shares of ReWalk Robotics stock opened at $3.68 on Friday. The firm’s fifty day simple moving average is $4.12. ReWalk Robotics Ltd. has a 1 year low of $3.41 and a 1 year high of $9.10. The firm has a market cap of $31.66 million, a P/E ratio of -1.18 and a beta of 2.06.
ReWalk Robotics (NASDAQ:LFWD – Get Free Report) last released its quarterly earnings results on Wednesday, May 15th. The company reported ($0.73) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.70) by ($0.03). The business had revenue of $5.28 million during the quarter, compared to analyst estimates of $5.55 million. ReWalk Robotics had a negative net margin of 134.52% and a negative return on equity of 35.41%. As a group, sell-side analysts expect that ReWalk Robotics Ltd. will post -1.94 EPS for the current year.
Analysts Set New Price Targets
View Our Latest Stock Analysis on ReWalk Robotics
Institutional Inflows and Outflows
An institutional investor recently bought a new position in ReWalk Robotics stock. Kent Lake Capital LLC purchased a new stake in ReWalk Robotics Ltd. (NASDAQ:LFWD – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 157,361 shares of the company’s stock, valued at approximately $823,000. Kent Lake Capital LLC owned 1.85% of ReWalk Robotics as of its most recent filing with the Securities and Exchange Commission. 26.76% of the stock is currently owned by institutional investors.
About ReWalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
Featured Articles
- Five stocks we like better than ReWalk Robotics
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- It’s Too Soon to Buy the Dip in Weight Loss Drugmakers
- Trading Stocks: RSI and Why it’s Useful
- Owens-Corning Stock: Good Value or Recession Red Flag?
- ESG Stocks, What Investors Should Know
- Datadog Exceeds Q2 Expectations, Solidifies Market Leadership
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.